✦ LIBER ✦

Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy

✍ Scribed by Anne F. Schott; Marilyn A. Roubidoux; Mark A. Helvie; Daniel F. Hayes; Celina G. Kleer; Lisa A. Newman; Lori J. Pierce; Kent A. Griffith; Susan Murray; Karen A. Hunt; Chintana Paramagul; Laurence H. Baker

Publisher: Springer US
Year: 2005
Tongue: English
Weight: 180 KB
Volume: 92
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-005-2510-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[18F]FDG-PET predicts complete pathologi

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy

✍ Alina Berriolo-Riedinger; Claude Touzery; Jean-Marc Riedinger; Michel Toubeau; B 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 246 KB

Relationship of clinical and pathologic

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer

✍ Csaba Gajdos; Paul Ian Tartter; Alison Estabrook; Michael A. Gistrak; Shabnam Ja 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

Bisphosphonates and pathologic complete

Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer

✍ Mariana Chavez-MacGregor; Erika Brown; Xiudong Lei; Jennifer Litton; Funda Meric 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Common and discriminative clinicopatholo

Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy

✍ Tomo Osako; Rie Horii; Masaaki Matsuura; Akiko Ogiya; Kaoru Domoto; Yumi Miyagi; 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 365 KB

Limitations of “Classic” Risk Factors to

Limitations of “Classic” Risk Factors to Predict Neoadjuvant Chemotherapy Response for Operable Breast Cancer

✍ Georgios C. Zografos; Dimosthenis Ziogas 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 111 KB

MRI evaluation of pathologically complet

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy

✍ Jeon Hor Chen; Byon Feig; Garima Agrawal; Hon Yu; Philip M. Carpenter; Rita S. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

## Abstract ## BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in evaluation of pathologically complete response and residual tumors in patients who were receiving neoadjuvant chemotherapy (NAC) for both positive and negative HER‐2 breast cancer. ## METHODS. Fift